Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 626

1.

Chondromodulin-1 directly suppresses growth of human cancer cells.

Mera H, Kawashima H, Yoshizawa T, Ishibashi O, Ali MM, Hayami T, Kitahara H, Yamagiwa H, Kondo N, Ogose A, Endo N, Kawashima H.

BMC Cancer. 2009 May 31;9:166. doi: 10.1186/1471-2407-9-166.

2.

Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.

Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C.

Cancer Res. 2009 Sep 1;69(17):6951-9. doi: 10.1158/0008-5472.CAN-09-0541. Epub 2009 Aug 18.

3.

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.

Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT.

Cell Physiol Biochem. 2009;24(3-4):253-62. doi: 10.1159/000233250. Epub 2009 Aug 3.

PMID:
19710540
4.

Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I.

Oshima Y, Sato K, Tashiro F, Miyazaki J, Nishida K, Hiraki Y, Tano Y, Shukunami C.

J Cell Sci. 2004 Jun 1;117(Pt 13):2731-44. Epub 2004 May 18.

5.

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.

Okuda Y, Nakamura H, Yoshida K, Enomoto H, Uyama H, Hirotani T, Funamoto M, Ito H, Everett AD, Hada T, Kawase I.

Cancer Sci. 2003 Dec;94(12):1034-41.

6.

[Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo].

Xia D, Xu L, Fu H, Qi XL, Quan Y, Yan LN.

Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):813-7. Chinese.

PMID:
18396636
7.

Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.

Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.

Hepatology. 2003 Mar;37(3):696-704.

PMID:
12601367
8.

Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.

Li KQ, Li WL, Peng SY, Shi XY, Tang HL, Liu YB.

Chin Med J (Engl). 2004 Sep;117(9):1364-9.

PMID:
15377430
9.

Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.

Goto T, Ishikawa H, Matsumoto K, Nishimura D, Kusaba M, Taura N, Shibata H, Miyaaki H, Ichikawa T, Hamasaki K, Nakao K, Maeshima Y, Eguchi K.

Int J Oncol. 2008 Jul;33(1):33-40.

PMID:
18575748
10.

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.

Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H.

Cancer Sci. 2009 Oct;100(10):1957-62. doi: 10.1111/j.1349-7006.2009.01241.x. Epub 2009 Jun 4.

11.

[The feasibility and mechanism of recombinant adenovirus Ad - p 14 ARF in gene therapy of liver cancer].

Song HF, Qian HL, Zhang XY, Liang X, Fu M, Lin C.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):641-5. Chinese.

PMID:
17274365
12.

[Exogenous mIkappaBalpha gene inhibits the growth of HepG2 heptocellular carcinoma cells].

Jin WD, Chen LH, Mu F.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Oct;24(10):1133-6. Chinese.

13.

Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.

Ushio K, Hashimoto T, Kitamura N, Tanaka T.

Mol Cancer Res. 2009 Jul;7(7):1179-88. doi: 10.1158/1541-7786.MCR-08-0289. Epub 2009 Jun 30.

14.

[Construction and study of replication-defective adenovirus targeting hepatocarcinoma].

Xu DY, Du ZY, Wang Y, Chen HH, Xu YJ, Lu YL.

Ai Zheng. 2006 Jul;25(7):798-804. Chinese.

PMID:
16831267
15.

Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.

Xue XB, Chen K, Wang CJ, Zheng JW, Yu Y, Peng ZH, Wu ZD.

Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):509-14.

16.

Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.

Wang YH, Dong YY, Wang WM, Xie XY, Wang ZM, Chen RX, Chen J, Gao DM, Cui JF, Ren ZG.

J Exp Clin Cancer Res. 2013 Aug 13;32(1):51. doi: 10.1186/1756-9966-32-51.

17.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109. Epub 2007 Jul 26.

PMID:
17698398
18.

[Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].

Liu FJ, Tan G, Li J, Sun XY.

Zhonghua Yi Xue Za Zhi. 2008 Aug 5;88(30):2147-51. Chinese.

PMID:
19080480
19.
20.

Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.

Nishina S, Shiraha H, Nakanishi Y, Tanaka S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J, Iwamuro M, Yagi T, Yamamoto K.

Oncol Rep. 2011 Sep;26(3):523-31. doi: 10.3892/or.2011.1336. Epub 2011 May 31.

PMID:
21637926
Items per page

Supplemental Content

Write to the Help Desk